Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen and Alzheimer's disease.

Andrea LeBlanc1

  • 1The Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada. andrea.leblanc@mcgill.ca

Current Opinion in Investigational Drugs (London, England : 2000)
|July 2, 2002
PubMed
Summary

Estrogen shows neuroprotective effects in Alzheimer's disease research. Basic science reveals molecular mechanisms, though clinical results vary, highlighting estrogen's potential therapeutic role.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic identification of synaptic caspase substrates.

Synapse (New York, N.Y.)·2017
Same author

Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells.

Oncotarget·2011
Same author

MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2010
Same author

Synthesis and evaluation of novel dipeptidyl benzoyloxymethyl ketones as caspase inhibitors.

Biochemical and biophysical research communications·2005
Same author

Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2004
Same author

Proteasomal degradation of caspase-6 in 17beta-estradiol-treated neurons.

Journal of neurochemistry·2004

Area of Science:

  • Neuroscience
  • Endocrinology
  • Pharmacology

Background:

  • Neurodegenerative diseases, including Alzheimer's disease, represent a significant unmet medical need.
  • Estrogen has emerged as a potential therapeutic agent due to its diverse biological functions.
  • Previous research has yielded mixed results regarding estrogen's efficacy in clinical settings.

Purpose of the Study:

  • To review the current understanding of estrogen's neuroprotective mechanisms.
  • To summarize findings on estrogen's potential benefits for neurons in Alzheimer's disease.
  • To reconcile discrepancies between basic science and clinical research outcomes.

Main Methods:

  • Review of preclinical studies investigating molecular pathways.
  • Analysis of clinical trial data on estrogen therapy for neurodegenerative conditions.
  • Synthesis of evidence from diverse research methodologies.

Main Results:

  • Basic research consistently demonstrates estrogen's neuroprotective properties at the molecular level.
  • Identified mechanisms include antioxidant effects, anti-inflammatory actions, and modulation of neurotransmitter systems.
  • Clinical studies show variable outcomes, suggesting the need for further investigation into optimal dosing and patient selection.

Conclusions:

  • Estrogen exhibits clear neuroprotective potential through identified molecular pathways.
  • Further research is warranted to optimize estrogen-based therapeutic strategies for Alzheimer's disease.
  • Bridging the gap between basic science findings and clinical application remains a key challenge.

Related Experiment Videos